Ion Channel Targets conference and exhibition: Second Conference Advisory
From: Select Biosciences Ltd
The agenda is now available for Select Conferences inaugural Ion Channel Targets conference and exhibition being held in Waltham, Boston, 20-21 September 2005. With easy worldwide access and inexpensive registration fees a high degree of interest is anticipated. Early registration is therefore recommended as delegate numbers will be limited.
We are delighted to announce a top quality agenda featuring 4 sessions and 20 speakers assembled from academia and industry. Chairing the first session, Ion Channels in Drug Discovery, is Dr. Michael Xie who is currently Associated Director of Biology at Synta Pharmaceuticals. On the afternoon of the first day Dr. Chris Mathes, Vice-President and General Manager of Sophion, will chair Advances in Ion Channel Technology and Screening. The second day will open with Ion Channels in Disease Biology chaired by our key note speaker Prof. David Clapham. He is currently Professor of Cardiovascular Research Investigator at the Howard Hughes Medical Institute and Professor of Neurobiology, Harvard Medical School. The meeting will close with Target Identification and Validation chaired by Dr. Maria Garcia, who is a Distinguished Senior Investigator in the Department of Ion Channels at Merck Research Laboratories.
In order to ensure the widest possible audience for our speakers registration fees start at just $399. So, if you want to see the latest research and equipment in ion channels whilst networking with your peers then this event is both affordable and unmissable.
Agenda
Day One 20th September
09:00 Ion Channels in Drug Discovery
Chaired by Dr. Michael Xie - Synta Pharmaceuticals
09:05 Combination Screening of Ion Channel Targets to Reduce False Positive Rate
Dr. Christopher Fanger, Hydra Biosciences
09:40 Ion Channel Targets in Drug Design for Cancer Therapeutics
Dr. Amit Banerjee, Wayne State University
10:15 Coffee and Networking in Exhibition
10:45 Novel Antagonists of Human Kv4.3: HT Ion Channel Screening in Transgenic C. elegans.
Dr. Andreas Kopke, Devgen nv
11:20 HERG, Repolarization and Sudden Cardiac Death
Dr. Arthur M. Brown, ChanTest, Inc.
11:55 Ion Channel Drug Discovery in Non-excitable Cells
Dr. Michael Xie, Synta Pharmaceuticals
12:30 Lunch and Networking in Exhibition
13:45 Advances in Ion Channel Technology and Screening
Chaired by Dr. Chris Mathes - Sophion Biosciences
13:50 Automated Patch Clamp Technology: Evaluation of QPatch® for Voltage Gated Na-channel Characterization
Dr. Mads Peder Gersdorff Korsgaard - Neurosearch
14:25 Utilising Ion Channel Cell Lines and High Throughput Electrophysiology in the Context of Drug Discovery and Development
Dr. Ray Helliwell, Cytomyx
15:00 Application of the Aequorin Assay Technology for Ion Channel Drug Discovery
Dr. Sandra Arpino, GlaxoSmithKline
15:35 Coffee and Networking in Exhibition
16:05 Cell Volume Cytometry: a new HTS
Dr. Susan Hua, University at Buffalo, SUNY
16:40 Using the Dynaflow System to Assess Novel Drug Properties at the 5HT3 Receptor
Dr. Geoffrey Tombaugh, Memory Pharmaceuticals Corp.
17:15 End of day
Informal cocktail reception hosted by Cytomyx at their facilities in Lexington, MA.
Day Two 21st September
09:00 Target Identification and Validation
Chaired by Dr. Maria Garcia- Merck Research Laboratories
09:05 Detection of Alternative Splicing Events in Ion Channels
Dr. Richard Einstein, ExonHit Therapeutics, Inc.
09:40 Identification and Validation of New Ion Channel Drug Discovery Targets
Dr. John Montana, Paradigm Therapeutics Ltd.
10:15 Coffee and Networking in the Exhibition
10:45 A High Throughput Mutation Screen of Human Ion Channel Genes in Common Inherited Neurological Disorders
Dr. Ronald G. Lafreniere, Emerillon Therapeutics Inc.
11:20 Quantitative Proteomics to Study Ion Channels in Brain
Dr. Jacek Wisniewski, Protana Inc.
11:55 Identification of novel classes of Kv1.x-Kvß1 channel modulators
utilizing protein-protein interaction assays
Dr. Rachel Ginham - University of Bristol
12:30 Lunch and Networking in Exhibition
13:45 Ion Channels in Disease Biology
Chaired by Prof. David Clapham
13:50 Ion Channels and Innate Immunity in Human Disease
Dr. Jatinder Ahluwalia, University College London
14:25 TRP Ion Channels as Drug Targets
Prof. David Clapham, Aldo R. Castañeda Professor of Cardiovascular Research, Investigator, Howard Hughes Medical Institute & Professor of Neurobiology, Harvard Medical School
15:00 CLIC4 as a Novel Target for Tumor Therapy
Dr. Kwang Suh, NIH/ NCI/ Center for Cancer Research
15:35 Coffee and Networking in Exhibition
16:05 Agonism of the Trp-p8 Ion Channel for the Treatment of Cancer
Dr. Sateesh Natarajan, Dendreon Corporation
16:40 Mechanosensitive Ion Channel Inhibitors: a new class of drugs
Prof. Frederick Sachs, University at Buffalo, SUNY
17:15 Close of Conference
